Page last updated: 2024-08-24

safranal and Hyperlipemia

safranal has been researched along with Hyperlipemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borji, A; Delkhosh, MB; Samarghandian, S; Samini, F	1

Other Studies

1 other study(ies) available for safranal and Hyperlipemia

Article	Year
Safranal treatment improves hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2013, Volume: 16, Issue:2 Topics: Animals; Antioxidants; Blood Glucose; Blood Proteins; Catalase; Cyclohexenes; Diabetes Mellitus, Experimental; Glutathione; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Lipids; Male; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Terpenes; Thiobarbituric Acid Reactive Substances	2013

Article

Year

Safranal treatment improves hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2013, Volume: 16, Issue:2

Topics: Animals; Antioxidants; Blood Glucose; Blood Proteins; Catalase; Cyclohexenes; Diabetes Mellitus, Experimental; Glutathione; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Lipids; Male; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Terpenes; Thiobarbituric Acid Reactive Substances

2013